These mAbs were obtained through Balb/c mice immunization with HER2 overexpressing Calu3 cells (lung adenocarcinoma)20 and were reported to recognize HER2 ECD epitope I and epitope III, respectively20,21, while trastuzumab recognises epitope IV14,22. The gene discussed is ERBB2; the disease is lung adenocarcinoma.